Novavax (NVAX) Change in Cash (2010 - 2026)

Novavax's Change in Cash history runs 17 years deep, the most recent figure standing at -$23.1 million for Q1 2026.

• On a quarterly basis, Change in Cash rose 91.33% year-over-year to -$23.1 million in Q1 2026; TTM through Mar 2026 was -$45.6 million, a 79.05% increase from a year earlier, with the FY2025 full-year figure at -$289.2 million, down 650.92% from the prior year.
• Change in Cash advanced to -$23.1 million in Q1 2026 per NVAX's latest filing, from -$27.3 million in the prior quarter.
• Across five years, Change in Cash topped out at $199.6 million in Q2 2024 and bottomed at -$711.9 million in Q1 2023.
• The 5-year median for Change in Cash is -$43.3 million (2024), against an average of -$76.2 million.
• Across the five-year window, Change in Cash plunged 1374.87% in 2023 and soared 267.75% in 2024, its largest moves.
• Year by year, Change in Cash stood at $55.8 million in 2022, then sank by 247.88% to -$82.6 million in 2023, then surged by 47.55% to -$43.3 million in 2024, then surged by 36.93% to -$27.3 million in 2025, then advanced by 15.3% to -$23.1 million in 2026.
• Per Business Quant, the three latest NVAX Change in Cash figures stand at -$23.1 million (Q1 2026), -$27.3 million (Q4 2025), and $14.4 million (Q3 2025).